Want to join the conversation?
$CA 1Q16 Q&A: Raimo Lenschow from Barclays, asks about slight change in strategy perhaps to more aggressively pursue acquisition again. Mike answers, I wouldn’t say that our strategy has changed at all, we’ve been consistent for the last two years that we’d spend between $300-500MM on acquisition, but number one focus is organic development.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?